Evolution of testing standards and key methodological assumptions challenge the conclusion of higher reinfection risk with Omicron.
2
In an era of limitless data and instant analysis, why are vaccine efficacies for the COVID-recovered omitted in pharma-sponsored studies? And, why…
7
9
A confusing "brief" by the CDC builds the evidence for accepting natural immunity, and then illogically concludes the opposite.
12
5
COVID-19 vaccine EUA for 5-11 year olds is expected, which will be used to construct rigid mandates. The FDA and CDC need to consider the specific…
3
6
A table circulating social media demonstrating the "inferiority" of natural immunity to vaccination, raises many more questions than it resolves.
1
This is Dissecting Data, a newsletter about Objective analysis of timely medical literature, particularly those with policy implications. .

Dissecting Data